Your cart is currently empty!
Ivosidenib
Ivosidenib works by blocking an abnormal enzyme that some cancer cells with specific changes in the IDH-1 gene make. Blocking the abnormal enzyme may make cancer cells differentiate to become more like normal cells and grow more slowly. Ivosidenib is a type of targeted therapy drug called an enzyme inhibitor. It is a small-molecule drug […]
Description
Ivosidenib works by blocking an abnormal enzyme that some cancer cells with specific changes in the IDH-1 gene make. Blocking the abnormal enzyme may make cancer cells differentiate to become more like normal cells and grow more slowly. Ivosidenib is a type of targeted therapy drug called an enzyme inhibitor. It is a small-molecule drug (a drug that can enter cells easily).US Brand Name(s)
Tibsovo
FDA Approved
Yes
Use in Cancer
Ivosidenib is approved to treat adults whose cancer has a certain mutation in the IDH1 gene, including:
- Acute myeloid leukemia (AML). It is used:
- Alone or with azacitidine in patients with newly-diagnosed cancer who are 75 years or older or who cannot receive intensive induction chemotherapy due to health problems.
- When the cancer has come back or has not gotten better after previous treatment.
- Cholangiocarcinoma (bile duct cancer) that has spread. It is used in adults whose cancer has been treated.
- Myelodysplastic syndrome that has come back or did not respond to treatment.
Ivosidenib is also being studied in the treatment of other types of cancer.
Reviews
There are no reviews yet.